NSD1 and Sotos syndrome: We studied 45 patients with a clinical diagnosis of Sotos syndrome, confirmed using molecular analysis, including 39 patients carrying a pathogenetic variant of the NSD1 gene (Group 1) and 6 patients with a 5q35 deletion (Group 2).